T.P. (Tim) Ahuis

PhD candidate part of the EQIPD (European Quality in Preclinical Data) consortium, a combined effort of universities and pharmaceutical companies, with the purpose of increasing the quality of preclinical data. The objectives are speeding up the discovery of new medications, in particular for neurodegenerative disease like Alzheimer's and a safer transition from preclinical to clinical research.